Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …
Global epidemiology and genetics of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC
develops in genetically susceptible individuals who are exposed to risk factors, especially in …
develops in genetically susceptible individuals who are exposed to risk factors, especially in …
Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis
M Tan, AS Bhadoria, F Cui, A Tan… - The lancet …, 2021 - thelancet.com
Background In 2016, of the estimated 257 million people living with chronic hepatitis B virus
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
(HBV) infection worldwide, only a small proportion was diagnosed and treated. The …
Incidence and mortality of non-AIDS-defining cancers among people living with HIV: a systematic review and meta-analysis
Background Non-AIDS-defining cancers (NADCs) are now becoming a rising cause of
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …
[图书][B] Prevention of mother-to-child transmission of hepatitis B virus (HBV): Guidelines on antiviral prophylaxis in pregnancy
World Health Organization - 2020 - books.google.com
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B …
A Avihingsanon, H Lu, CL Leong, CC Hung… - The Lancet …, 2023 - thelancet.com
Background For most adults with HIV-1 and hepatitis B virus (HBV) coinfection, initial
recommended treatment is a tenofovir-containing antiretroviral regimen, but no randomised …
recommended treatment is a tenofovir-containing antiretroviral regimen, but no randomised …
HBV/HIV coinfection: impact on the development and clinical treatment of liver diseases
Z Cheng, P Lin, N Cheng - Frontiers in medicine, 2021 - frontiersin.org
Hepatitis B virus (HBV) infection is a common contributor to chronic hepatitis, liver cirrhosis,
and hepatocellular carcinoma. Approximately 10% of people with human immunodeficiency …
and hepatocellular carcinoma. Approximately 10% of people with human immunodeficiency …
Risk of HCC with hepatitis B viremia among HIV/HBV‐coinfected persons in North America
HN Kim, CW Newcomb, DM Carbonari, JA Roy… - …, 2021 - Wiley Online Library
Background and Aims Chronic HBV is the predominant cause of HCC worldwide. Although
HBV coinfection is common in HIV, the determinants of HCC in HIV/HBV coinfection are …
HBV coinfection is common in HIV, the determinants of HCC in HIV/HBV coinfection are …
[HTML][HTML] Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
E Amponsah-Dacosta - World journal of gastroenterology, 2021 - ncbi.nlm.nih.gov
Elimination of viral hepatitis in sub-Saharan Africa by 2030 is an ambitious feat. However, as
stated by the World Health Organization, there are unprecedented opportunities to act and …
stated by the World Health Organization, there are unprecedented opportunities to act and …
Hepatitis B virus research in South Africa
Despite being vaccine-preventable, hepatitis B virus (HBV) infection remains the seventh
leading cause of mortality in the world. In South Africa (SA), over 1.9 million people are …
leading cause of mortality in the world. In South Africa (SA), over 1.9 million people are …